27.44 USD
-0.17 (-0.62%)
At close: Jan 30, 2026
27.44 USD
0 (0%)
After Hours: 1/30/2026, 8:00:00 PM
Taking everything into account, AGIO scores 4 out of 10 in our fundamental rating. AGIO was compared to 525 industry peers in the Biotechnology industry. AGIO has a great financial health rating, but its profitability evaluates not so good. AGIO is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year AGIO has reported negative net income.
- In the past year AGIO has reported a negative cash flow from operations.
- The reported net income has been mixed in the past 5 years: AGIO reported negative net income in multiple years.
- In the past 5 years AGIO always reported negative operating cash flow.
1.2 Ratios
- AGIO has a better Return On Assets (-28.96%) than 67.81% of its industry peers.
- AGIO's Return On Equity of -31.24% is fine compared to the rest of the industry. AGIO outperforms 75.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.96% | ||
| ROE | -31.24% | ||
| ROIC | N/A |
ROA(3y)-5.26%
ROA(5y)11.49%
ROE(3y)-6.92%
ROE(5y)4.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AGIO has a better Gross Margin (87.22%) than 89.71% of its industry peers.
- AGIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.22% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- AGIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, AGIO has more shares outstanding
- AGIO has less shares outstanding than it did 5 years ago.
- AGIO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- AGIO has an Altman-Z score of 8.80. This indicates that AGIO is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of AGIO (8.80) is better than 80.57% of its industry peers.
- AGIO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 8.8 |
ROIC/WACCN/A
WACC8.9%
2.3 Liquidity
- AGIO has a Current Ratio of 13.82. This indicates that AGIO is financially healthy and has no problem in meeting its short term obligations.
- AGIO has a better Current ratio (13.82) than 90.10% of its industry peers.
- AGIO has a Quick Ratio of 13.39. This indicates that AGIO is financially healthy and has no problem in meeting its short term obligations.
- AGIO's Quick ratio of 13.39 is amongst the best of the industry. AGIO outperforms 89.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.82 | ||
| Quick Ratio | 13.39 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 7.92% over the past year.
- The earnings per share for AGIO have been decreasing by -24.03% on average. This is quite bad
- Looking at the last year, AGIO shows a very strong growth in Revenue. The Revenue has grown by 36.26%.
EPS 1Y (TTM)7.92%
EPS 3Y-24.03%
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)36.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.69%
3.2 Future
- Based on estimates for the next years, AGIO will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.13% on average per year.
- AGIO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 86.69% yearly.
EPS Next Y-3.08%
EPS Next 2Y3.13%
EPS Next 3Y8.25%
EPS Next 5Y16.13%
Revenue Next Year30.21%
Revenue Next 2Y74.35%
Revenue Next 3Y92.31%
Revenue Next 5Y86.69%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- AGIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AGIO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.13%
EPS Next 3Y8.25%
5. Dividend
5.1 Amount
- AGIO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AGIOS PHARMACEUTICALS INC / AGIO FAQ
What is the ChartMill fundamental rating of AGIOS PHARMACEUTICALS INC (AGIO) stock?
ChartMill assigns a fundamental rating of 4 / 10 to AGIO.
What is the valuation status of AGIOS PHARMACEUTICALS INC (AGIO) stock?
ChartMill assigns a valuation rating of 0 / 10 to AGIOS PHARMACEUTICALS INC (AGIO). This can be considered as Overvalued.
Can you provide the profitability details for AGIOS PHARMACEUTICALS INC?
AGIOS PHARMACEUTICALS INC (AGIO) has a profitability rating of 2 / 10.